🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 81720R406 (prev. 81720R208 )
- Market Cap
- Micro Cap
- IPO
- 12/8/2016 · $8.00/share
Business: SenesTech, Inc. has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's first fertility control product candidate, ContraPest, will be marketed for use initially in controlling rat infestations. SenesTech believe its non-lethal approach, targeting reproduction, is more humane, less harmful to the environment, and more effective in providing a sustainable solution to pest infestations than traditional lethal pest management methods.
Notes: November 15, 2022 -- SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”) (www.senestech.com) today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre-split shares. The reverse stock split will become effective at 11:59 p.m, Eastern Time, on November 15, 2022.The new CUSIP number for the Common Stock following the reverse stock split is 81720R406.<p> February 3, 2020 -- the Company’s board of directors set the ratio for the Reverse Stock Split at one-for-twenty. On February 4, 2020, at 4:01 p.m. Eastern Time, the Certificate of Amendment to the Company’s Certificate of Incorporation (the “Amendment”), which the Company filed with the Secretary of State of the State of Delaware to effect the Reverse Stock Split, will become effective. The Company’s common stock is expected to begin trading on the Nasdaq Capital Market on a split-adjusted basis when the market opens on Wednesday, February 5, 2020. The new CUSIP number for the Company’s common stock following the Reverse Stock Split is 81720R208.
Company Contact
- CEO
- Joel Fruendt
- CFO
- Tom Chesterman
- Headquarters
- 23460 N. 19th Avenue, Suite 110, Phoenix, AZ 85027
- Phone
- 928-779-4143
- Investor Relations
- Robert Blum, Lytham Partners · 602-889-9700 · senestech@lythampartners.com